Education
About Us
Working with TipRanks
Follow Us
BioInvent International AB (SE:BINV)
:BINV
Total Valuation
BioInvent International AB has a market cap or net worth of kr1.84B. The enterprise value is kr1.48B.
Market Capkr1.84B
Enterprise Valuekr1.48B
Share Statistics
BioInvent International AB has 65,804,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding65,804,360
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioInvent International AB’s return on equity (ROE) is -0.48 and return on invested capital (ROIC) is -52.17%.
Return on Equity (ROE)-0.48
Return on Assets (ROA)-0.43
Return on Invested Capital (ROIC)-52.17%
Return on Capital Employed (ROCE)-0.53
Revenue Per Employee378.69K
Profits Per Employee-3.99M
Employee Count118
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioInvent International AB is ―. BioInvent International AB’s PEG ratio is -0.20.
PE Ratio―
PS Ratio56.69
PB Ratio2.86
Price to Fair Value2.86
Price to FCF-6.49
Price to Operating Cash Flow-7.65
PEG Ratio-0.20
Income Statement
In the last 12 months, BioInvent International AB had revenue of 44.69M and earned -429.38M in profits. Earnings per share was -6.53.
Revenue44.69M
Gross Profit44.69M
Operating Income-471.06M
Pretax Income-429.24M
Net Income-429.38M
EBITDA-409.38M
Earnings Per Share (EPS)-6.53
Cash Flow
In the last 12 months, operating cash flow was -255.51M and capital expenditures -6.83M, giving a free cash flow of -262.35M billion.
Operating Cash Flow-255.51M
Free Cash Flow-262.35M
Free Cash Flow per Share-3.99
Dividends & Yields
BioInvent International AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.48
52-Week Price Change-27.89%
50-Day Moving Average29.22
200-Day Moving Average31.94
Relative Strength Index (RSI)42.95
Average Volume (3m)91.72K
Important Dates
BioInvent International AB upcoming earnings date is Feb 26, 2026, Before Open (Confirmed).
Last Earnings DateOct 29, 2025
Next Earnings DateFeb 26, 2026
Ex-Dividend Date―
Financial Position
BioInvent International AB as a current ratio of 9.91, with Debt / Equity ratio of 1.60%
Current Ratio9.91
Quick Ratio9.79
Debt to Market Cap0.00
Net Debt to EBITDA1.02
Interest Coverage Ratio-848.75
Taxes
In the past 12 months, BioInvent International AB has paid 135.00K in taxes.
Income Tax135.00K
Effective Tax Rate>-0.01
Enterprise Valuation
BioInvent International AB EV to EBITDA ratio is -5.17, with an EV/FCF ratio of -5.42.
EV to Sales47.35
EV to EBITDA-5.17
EV to Free Cash Flow-5.42
EV to Operating Cash Flow-5.56
Balance Sheet
BioInvent International AB has kr690.46M in cash and marketable securities with kr10.69M in debt, giving a net cash position of kr679.77M billion.
Cash & Marketable Securitieskr690.46M
Total Debtkr10.69M
Net Cashkr679.77M
Net Cash Per Sharekr10.33
Tangible Book Value Per Sharekr13.46
Margins
Gross margin is 100.00%, with operating margin of -1054.15%, and net profit margin of -960.87%.
Gross Margin100.00%
Operating Margin-1054.15%
Pretax Margin-960.57%
Net Profit Margin-960.87%
EBITDA Margin-916.14%
EBIT Margin-959.33%
Analyst Forecast
The average price target for BioInvent International AB is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast533.73%
EPS Growth Forecast20.92%